BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 36726797)

  • 1. Bmi-1: A master regulator of head and neck cancer stemness.
    Herzog AE; Somayaji R; Nör JE
    Front Oral Health; 2023; 4():1080255. PubMed ID: 36726797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IL-6R and Bmi-1 axis controls self-renewal and chemoresistance of head and neck cancer stem cells.
    Herzog AE; Warner KA; Zhang Z; Bellile E; Bhagat MA; Castilho RM; Wolf GT; Polverini PJ; Pearson AT; Nör JE
    Cell Death Dis; 2021 Oct; 12(11):988. PubMed ID: 34689150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Cancer Stem Cells: Therapeutic Implications and Challenges.
    Shahoumi LA
    Front Oral Health; 2021; 2():685236. PubMed ID: 35048028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.
    Nör C; Zhang Z; Warner KA; Bernardi L; Visioli F; Helman JI; Roesler R; Nör JE
    Neoplasia; 2014 Feb; 16(2):137-46. PubMed ID: 24709421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
    Bourguignon LYW; Earle C; Shiina M
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTOR Inhibition Ablates Cisplatin-Resistant Salivary Gland Cancer Stem Cells.
    Nakano T; Warner KA; Oklejas AE; Zhang Z; Rodriguez-Ramirez C; Shuman AG; Nör JE
    J Dent Res; 2021 Apr; 100(4):377-386. PubMed ID: 33073679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma.
    Kumar HA; Desai A; Mohiddin G; Mishra P; Bhattacharyya A; Nishat R
    J Pharm Bioallied Sci; 2023 Jul; 15(Suppl 2):S826-S830. PubMed ID: 37694019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells.
    Jagust P; Alcalá S; Sainz Jr B; Heeschen C; Sancho P
    World J Stem Cells; 2020 Nov; 12(11):1410-1428. PubMed ID: 33312407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cells in head and neck squamous cell carcinoma: a review.
    Satpute PS; Hazarey V; Ahmed R; Yadav L
    Asian Pac J Cancer Prev; 2013; 14(10):5579-87. PubMed ID: 24289547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 Inhibits Bmi-1-driven Self-Renewal and Defines Salivary Gland Cancer Stemness.
    Rodriguez-Ramirez C; Zhang Z; Warner KA; Herzog AE; Mantesso A; Zhang Z; Yoon E; Wang S; Wicha MS; Nör JE
    Clin Cancer Res; 2022 Nov; 28(21):4757-4770. PubMed ID: 36048559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma.
    Bourguignon LY; Wong G; Shiina M
    J Biol Chem; 2016 May; 291(20):10571-85. PubMed ID: 27002147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of salivary gland cancer stem cells requires mTOR signaling.
    Andrade NP; Warner KA; Zhang Z; Pearson AT; Mantesso A; Guimaraēs DM; Altemani A; Mariano FV; Nunes FD; Nör JE
    Cell Death Dis; 2021 Jan; 12(1):108. PubMed ID: 33479203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategy of differentiation therapy: effect of dual-frequency ultrasound on the induction of liver cancer stem-like cells on a HA-based multilayer film system.
    Lee IC; Fadera S; Liu HL
    J Mater Chem B; 2019 Sep; 7(35):5401-5411. PubMed ID: 31414097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling the Behavior of Distinct Populations of Head and Neck Cancer Stem Cells.
    Almeida LO; Guimarães DM; Squarize CH; Castilho RM
    Cancers (Basel); 2016 Jan; 8(1):. PubMed ID: 26742076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cancer stem cells in squamous cell carcinoma.
    Chen D; Wang CY
    Precis Clin Med; 2019 Sep; 2(3):152-165. PubMed ID: 31598386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oct4 is a critical regulator of stemness in head and neck squamous carcinoma cells.
    Koo BS; Lee SH; Kim JM; Huang S; Kim SH; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
    Oncogene; 2015 Apr; 34(18):2317-24. PubMed ID: 24954502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Stem Cells and Treatment of Cancer: An Update and Future Perspectives.
    Khan M; Naeem M; Chaudary SA; Ahmed A; Ahmed A
    Curr Stem Cell Res Ther; 2023 Oct; ():. PubMed ID: 37818567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perivascular stem cell niche in head and neck cancer.
    Ritchie KE; Nör JE
    Cancer Lett; 2013 Sep; 338(1):41-6. PubMed ID: 22842095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma.
    Kerk SA; Finkel KA; Pearson AT; Warner KA; Zhang Z; Nör F; Wagner VP; Vargas PA; Wicha MS; Hurt EM; Hollingsworth RE; Tice DA; Nör JE
    Clin Cancer Res; 2017 May; 23(10):2516-2527. PubMed ID: 27780858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.